BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 37469864)

  • 1. Overview of research progress and application of experimental models of colorectal cancer.
    Liu L; Yan Q; Chen Z; Wei X; Li L; Tang D; Tan J; Xu C; Yu C; Lai Y; Fan M; Tao L; Shen W; Li L; Wu M; Cheng H; Sun D
    Front Pharmacol; 2023; 14():1193213. PubMed ID: 37469864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models of colorectal cancer: Past, present and future perspectives.
    Bürtin F; Mullins CS; Linnebacher M
    World J Gastroenterol; 2020 Apr; 26(13):1394-1426. PubMed ID: 32308343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of phototherapeutic-based nanoparticles in colorectal cancer.
    Yan J; Wang C; Jiang X; Wei Y; Wang Q; Cui K; Xu X; Wang F; Zhang L
    Int J Biol Sci; 2021; 17(5):1361-1381. PubMed ID: 33867852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy in colorectal cancer treatment--The state of the art in preclinical research.
    Kawczyk-Krupka A; Bugaj AM; Latos W; Zaremba K; Wawrzyniec K; Kucharzewski M; Sieroń A
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():158-174. PubMed ID: 26238625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the development of transplanted colorectal cancer mouse models.
    Yang YS; Liu CY; Wen D; Gao DZ; Lin S; He HF; Zhao XF
    Transl Res; 2022 Nov; 249():128-143. PubMed ID: 35850446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates.
    Guo M; You C; Dou J
    Biomed Pharmacother; 2018 Nov; 107():1318-1325. PubMed ID: 30257347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fungi in the diagnosis of colorectal cancer.
    Li XH; Luo MM; Wang ZX; Wang Q; Xu B
    Mycology; 2024; 15(1):17-29. PubMed ID: 38558845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From mice to men: Murine models of colorectal cancer for use in translational research.
    Evans JP; Sutton PA; Winiarski BK; Fenwick SW; Malik HZ; Vimalachandran D; Tweedle EM; Costello E; Palmer DH; Park BK; Kitteringham NR
    Crit Rev Oncol Hematol; 2016 Feb; 98():94-105. PubMed ID: 26558688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal Cancer in Brunei Darussalam: An Overview and Rationale for National Screening Programme.
    Lim MA; Chong VH; Ong SK; Lim YC
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3571-3580. PubMed ID: 31870096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Murine Models for Colorectal Cancer Research.
    Neto Í; Rocha J; Gaspar MM; Reis CP
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant circulating tumor DNA methylation and exosomal microRNA biomarkers for early detection of colorectal cancer.
    Zhang X; Hou H; Jiang M; Zhang X
    Mol Biol Rep; 2023 Mar; 50(3):2743-2750. PubMed ID: 36583782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer Screening in China: Status, Challenges, and Prospects - China, 2022.
    Chen H; Lu B; Dai M
    China CDC Wkly; 2022 Apr; 4(15):322-328. PubMed ID: 35548454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular senescence: a promising therapeutic target in colorectal cancer.
    Wu Y; Xie M; Sun JH; Li CC; Dong GH; Zhang QS; Cui PL
    Future Oncol; 2022 Sep; 18(30):3463-3470. PubMed ID: 36069254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism.
    Ou S; Wang H; Tao Y; Luo K; Ye J; Ran S; Guan Z; Wang Y; Hu H; Huang R
    Front Cell Infect Microbiol; 2022; 12():1020583. PubMed ID: 36523635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tests and investigations for colorectal cancer screening.
    Carroll MR; Seaman HE; Halloran SP
    Clin Biochem; 2014 Jul; 47(10-11):921-39. PubMed ID: 24769265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor organoid model of colorectal cancer (Review).
    Yang C; Xiao W; Wang R; Hu Y; Yi K; Sun X; Wang G; Xu X
    Oncol Lett; 2023 Aug; 26(2):328. PubMed ID: 37415635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular methods for colorectal cancer screening: Progress with next-generation sequencing evolution.
    Abbes S; Baldi S; Sellami H; Amedei A; Keskes L
    World J Gastrointest Oncol; 2023 Mar; 15(3):425-442. PubMed ID: 37009313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based microsimulation model for colorectal cancer: validation and application.
    Rutter CM; Savarino JE
    Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1992-2002. PubMed ID: 20647403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects.
    Li J; Zhang AH; Wu FF; Wang XJ
    Front Oncol; 2022; 12():841552. PubMed ID: 35223525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer models for novel drug discovery.
    Golovko D; Kedrin D; Yilmaz ÖH; Roper J
    Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.